NO923918L - Nye t-celle-lymfom cdna-kloner - Google Patents

Nye t-celle-lymfom cdna-kloner

Info

Publication number
NO923918L
NO923918L NO92923918A NO923918A NO923918L NO 923918 L NO923918 L NO 923918L NO 92923918 A NO92923918 A NO 92923918A NO 923918 A NO923918 A NO 923918A NO 923918 L NO923918 L NO 923918L
Authority
NO
Norway
Prior art keywords
novel
expressed
proteins
cell
dna sequences
Prior art date
Application number
NO92923918A
Other languages
English (en)
Other versions
NO923918D0 (no
NO307341B1 (no
Inventor
Carol L Macleod
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO923918D0 publication Critical patent/NO923918D0/no
Publication of NO923918L publication Critical patent/NO923918L/no
Publication of NO307341B1 publication Critical patent/NO307341B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO923918A 1990-04-13 1992-10-08 Nye T-celle lymfom cDNA kloner og fremstilling av T- lymfomcelleprotein NO307341B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50968490A 1990-04-13 1990-04-13
PCT/US1991/002518 WO1991016430A1 (en) 1990-04-13 1991-04-12 NOVEL T-CELL LYMPHOMA cDNA CLONES

Publications (3)

Publication Number Publication Date
NO923918D0 NO923918D0 (no) 1992-10-08
NO923918L true NO923918L (no) 1992-12-01
NO307341B1 NO307341B1 (no) 2000-03-20

Family

ID=24027673

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923918A NO307341B1 (no) 1990-04-13 1992-10-08 Nye T-celle lymfom cDNA kloner og fremstilling av T- lymfomcelleprotein

Country Status (22)

Country Link
US (2) US5312733A (no)
EP (1) EP0527813B1 (no)
JP (1) JPH05506989A (no)
KR (1) KR100212371B1 (no)
AT (1) ATE141105T1 (no)
AU (1) AU664535B2 (no)
CA (1) CA2080018C (no)
DE (1) DE69121240T2 (no)
DK (1) DK0527813T3 (no)
ES (1) ES2093100T3 (no)
FI (1) FI108037B (no)
GR (1) GR3021478T3 (no)
HK (1) HK1006726A1 (no)
IE (1) IE75903B1 (no)
IL (1) IL97775A (no)
NO (1) NO307341B1 (no)
NZ (1) NZ237669A (no)
PT (1) PT97355B (no)
RU (1) RU2116346C1 (no)
SA (1) SA92120348B1 (no)
WO (1) WO1991016430A1 (no)
ZA (1) ZA912489B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784163B1 (en) * 1990-04-13 2004-08-31 Macleod Carol L. Inhibition of cationic amino acid transporter protein and uses thereof
WO1994004567A1 (en) * 1992-08-21 1994-03-03 La Jolla Cancer Research Foundation A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids
US7138500B1 (en) * 1993-05-07 2006-11-21 Immunex Corporation Antibodies to human 4-1BB
US7211259B1 (en) 1993-05-07 2007-05-01 Immunex Corporation 4-1BB polypeptides and DNA encoding 4-1BB polypeptides
WO1994026290A1 (en) * 1993-05-07 1994-11-24 Immunex Corporation Cytokine designated 4-1bb ligand and human receptor that binds thereto
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
CA2381284A1 (en) * 1999-08-04 2001-02-15 Amgen Inc. Fhm, a novel member of the tnf ligand supergene family
WO2001010908A1 (en) * 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
AU2002337442A1 (en) * 2001-09-24 2003-04-07 University Of Aarhus Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia
EP1913401A4 (en) * 2005-08-03 2009-11-18 Astrazeneca Ab METHOD FOR IDENTIFYING AN AGENT THAT MODULATES TRANSPORTATION OF ARGININE IN A CHONDROCYTE
CA2629532C (en) 2005-11-18 2016-08-09 University Health Network Method of expanding double negative t cells
KR101790647B1 (ko) * 2009-06-10 2017-10-26 스티븐 사니그 리서치 인스티튜트 리미티드 표현형적 유연성을 나타내는 세포 제조 방법

Also Published As

Publication number Publication date
IE911250A1 (en) 1991-10-23
PT97355A (pt) 1991-12-31
FI108037B (fi) 2001-11-15
EP0527813B1 (en) 1996-08-07
IL97775A (en) 1998-04-05
NO923918D0 (no) 1992-10-08
AU7745791A (en) 1991-11-11
IL97775A0 (en) 1992-06-21
PT97355B (pt) 1998-08-31
IE75903B1 (en) 1997-10-08
ES2093100T3 (es) 1996-12-16
KR100212371B1 (ko) 1999-08-02
FI924575A (fi) 1992-10-09
US5440017A (en) 1995-08-08
US5312733A (en) 1994-05-17
AU664535B2 (en) 1995-11-23
JPH05506989A (ja) 1993-10-14
RU2116346C1 (ru) 1998-07-27
NZ237669A (en) 1992-08-26
CA2080018C (en) 2003-10-14
ZA912489B (en) 1992-01-29
EP0527813A4 (en) 1993-05-05
SA92120348B1 (ar) 2004-01-24
FI924575A0 (fi) 1992-10-09
DE69121240D1 (de) 1996-09-12
NO307341B1 (no) 2000-03-20
ATE141105T1 (de) 1996-08-15
CA2080018A1 (en) 1991-10-14
DE69121240T2 (de) 1997-01-09
WO1991016430A1 (en) 1991-10-31
GR3021478T3 (en) 1997-01-31
EP0527813A1 (en) 1993-02-24
HK1006726A1 (en) 1999-03-12
KR930700657A (ko) 1993-03-15
DK0527813T3 (da) 1996-12-30

Similar Documents

Publication Publication Date Title
NO923918L (no) Nye t-celle-lymfom cdna-kloner
DE69535375D1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
EP0590071A4 (en) Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof
EP0281604A4 (en) BINDING MOLECULES WITH SINGLE POLYPEPTIDE CHAIN.
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
DE69940964D1 (de) Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
ATE212056T1 (de) Methoden zur herstellung von rna viren aus cdna
ATE152771T1 (de) Methode zur herstellung und prüfung von verwendbaren peptiden
ATE247164T1 (de) Insulinartigen wachstumsfaktor bindendes protein
ATE190491T1 (de) Peptide als diagnose- und therapiemittel für spondyloarthropathien
DE69434118D1 (de) Klonierung und rekombinante herstellung des crf-rezeptors (crf=corticotropin ausloese faktor)
MacLeod T-cell lymphoma CDNA clones
RU2004118303A (ru) Быстросозревающие флуоресцирующие белки и способы их применения
Husain et al. Isolation, molecular cloning and in vitro expression of rhesus monkey (Macaca mulatta) prominin‐1. s1 complementary DNA encoding a potential hematopoietic stem cell antigen
Saito et al. Differential expression of the leucocyte
RU97106012A (ru) Новые связывающие рка белки и их использование

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees